✦ LIBER ✦

Safety of cabazitaxel in senior adults with metastatic castration-resistant prostate cancer: Results of the European compassionate-use programme

✍ Scribed by Heidenreich, Axel; Bracarda, Sergio; Mason, Malcolm; Ozen, Haluk; Sengelov, Lisa; Van Oort, Inge; Papandreou, Christos; Fossa, Sophie; Hitier, Simon; Climent, Miguel Angel

Book ID: 121501298
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 452 KB
Volume: 50
Category: Article
ISSN: 0959-8049
DOI: 10.1016/j.ejca.2014.01.006

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

106 Cabazitaxel adverse events are manag

106 Cabazitaxel adverse events are manageable in senior adults with metastatic castration-resistant prostate cancer (mCRPC): Results of the European Compassionate Use Programme

✍ Heidenreich, A.; Bracarda, S.; Mason, M.; Ozen, H.; Sengelov, L.; Gerritsen, W.; 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 102 KB

Cabazitaxel in Patients With Metastatic

Cabazitaxel in Patients With Metastatic Castration-Resistant Prostate Cancer: Results of a Compassionate Use Program in The Netherlands

✍ Wissing, Michel D.; van Oort, Inge M.; Gerritsen, Winald R.; van den Eertwegh, A 📂 Article 📅 2013 🏛 CIG Media Group, LP. 🌐 English ⚖ 582 KB

Cabazitaxel Plus Prednisone for Metastat

Cabazitaxel Plus Prednisone for Metastatic Castration-resistant Prostate Cancer Progressing After Docetaxel: Results from the German Compassionate-use Programme

✍ Heidenreich, Axel; Scholz, Hans-Jörg; Rogenhofer, Sebastian; Arsov, Christian; R 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 193 KB

7044 POSTER Cabazitaxel Plus Prednisone

7044 POSTER Cabazitaxel Plus Prednisone for Patients With Metastatic Castration-resistant Prostate Cancer Previously Treated With a Docetaxel-containing Regimen – Interim Analysis Results From an Ongoing Compassionate-use Programme

✍ Heidenreich, A.; Scholz, H.J.; van Oort, I.; Bavbek, S.; Mueller, S.; Ozguroglu, 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 43 KB

129 Cabazitaxel for metastatic castratio

129 Cabazitaxel for metastatic castration resistant prostate cancer (mCRPC): Interim safety and quality of life (QOL) data from the UK early access programme

✍ A.K. Bahl; S. Masson; Z. Malik; A. Birtle; S. Sundar; R. Jones; N. James; M. Mas 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 20 KB

128 Cabazitaxel plus prednisone for pati

128 Cabazitaxel plus prednisone for patients with metastatic castration-resistant prostate cancer previously treated with a docetaxel-containing regimen: Interim analysis on treatment associated side effects resulting from a compassionate-use programme (CUP)

✍ A. Heidenreich; P. Albers; C. Bokemeyer; P. Goebell; J. Gschwend; K. Miller; S M 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 37 KB